We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Develop Optical Imaging Products

By HospiMedica staff writers
Posted on 18 Nov 2003
An alliance to develop optical imaging products for the laboratory market has been announced by Imaging Diagnostic Systems, Inc. More...
(IDSI, Fort Lauderdale, FL, USA) and the Rumbaugh-Goodwin Institute for Cancer Research, Inc. (Plantation, FL, USA).

IDSI, which has developed a breast imaging product, is now developing a new line of products based on the company's optical computed tomography (CT) and fluorescent imaging technologies, called Laser Imaging for Lab Animals (LILA). The first model is a miniature optical CT scanner for imaging green fluorescent protein, derived from the DNA of jellyfish. The Rumbaugh-Goodwin Institute has expertise in optical imaging for determining the efficacy of new anticancer treatments and spontaneously metastasizing models of human breast cancer. The institute's main goal is to develop cancer therapies targeting tumors, with minimal cellular damage and toxicity for the patient.

"With this agreement, IDSI is addressing a new market, targeting pharmaceutical developers and researchers who monitor cancer growth,” noted Linda Grable, CEO of IDSI. "It is exciting and beneficial to be adding a new product line to complement our breast imaging product.”






Related Links:
IDSI
Rumbaugh

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.